^
+ Follow IMBRUVICA Tag
Array
(
    [results] => Array
        (
            [0] => Array
                (
                    [ArticleID] => 1290305
                    [Title] => FDA approves Pharmacyclics, J&J drug for new use in treating rare bone marrow leukemia
                    [Summary] => 

The Food and Drug Administration on Wednesday approved a cancer drug from Pharmacyclics and Johnson & Johnson for a new use against a rare blood and bone marrow disease.

[DatePublished] => 2014-02-14 00:23:17 [ColumnID] => 0 [Focus] => 0 [AuthorID] => [AuthorName] => [SectionName] => Health And Family [SectionUrl] => health-and-family [URL] => http://premium.mofusecdn.com/80f2c8ee7542896ed15e3296a6cd0df2/cache/post-images/d9a6eed5345ed108fbde6630bebb911d.570.0.0.jpg ) [1] => Array ( [ArticleID] => 1257009 [Title] => FDA approves new drug for rare blood cancer [Summary] =>

The Food and Drug Administration on Wednesday approved a new drug from Pharmacyclics and Janssen Biotech Inc. to treat a rare and aggressive form of blood cancer.

[DatePublished] => 2013-11-15 03:26:01 [ColumnID] => 0 [Focus] => 0 [AuthorID] => [AuthorName] => [SectionName] => Health And Family [SectionUrl] => health-and-family [URL] => http://premium.mofusecdn.com/80f2c8ee7542896ed15e3296a6cd0df2/cache/post-images/d9a6eed5345ed108fbde6630bebb911d.570.0.0.jpg ) ) )
IMBRUVICA
Array
(
    [results] => Array
        (
            [0] => Array
                (
                    [ArticleID] => 1290305
                    [Title] => FDA approves Pharmacyclics, J&J drug for new use in treating rare bone marrow leukemia
                    [Summary] => 

The Food and Drug Administration on Wednesday approved a cancer drug from Pharmacyclics and Johnson & Johnson for a new use against a rare blood and bone marrow disease.

[DatePublished] => 2014-02-14 00:23:17 [ColumnID] => 0 [Focus] => 0 [AuthorID] => [AuthorName] => [SectionName] => Health And Family [SectionUrl] => health-and-family [URL] => http://premium.mofusecdn.com/80f2c8ee7542896ed15e3296a6cd0df2/cache/post-images/d9a6eed5345ed108fbde6630bebb911d.570.0.0.jpg ) [1] => Array ( [ArticleID] => 1257009 [Title] => FDA approves new drug for rare blood cancer [Summary] =>

The Food and Drug Administration on Wednesday approved a new drug from Pharmacyclics and Janssen Biotech Inc. to treat a rare and aggressive form of blood cancer.

[DatePublished] => 2013-11-15 03:26:01 [ColumnID] => 0 [Focus] => 0 [AuthorID] => [AuthorName] => [SectionName] => Health And Family [SectionUrl] => health-and-family [URL] => http://premium.mofusecdn.com/80f2c8ee7542896ed15e3296a6cd0df2/cache/post-images/d9a6eed5345ed108fbde6630bebb911d.570.0.0.jpg ) ) )
abtest
Are you sure you want to log out?
X
Login

Philstar.com is one of the most vibrant, opinionated, discerning communities of readers on cyberspace. With your meaningful insights, help shape the stories that can shape the country. Sign up now!

Get Updated:

Signup for the News Round now

FORGOT PASSWORD?
SIGN IN
or sign in with